{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CDKs", "Coronary heart disease", "Flavopiridol", "Hematologic malignancies", "Infectious disease", "Inflammation", "Neurodegenerative diseases", "Solid tumors"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27771926", "DateCompleted": {"Year": "2017", "Month": "07", "Day": "10"}, "DateRevised": {"Year": "2017", "Month": "07", "Day": "13"}, "Article": {"ArticleDate": [], "ELocationID": [], "Language": ["eng"], "Journal": {"ISSN": "0065-2598", "JournalIssue": {"Volume": "929", "PubDate": {"Year": "2016"}}, "Title": "Advances in experimental medicine and biology", "ISOAbbreviation": "Adv Exp Med Biol"}, "ArticleTitle": "Potential Use of Flavopiridol in Treatment of Chronic Diseases.", "Pagination": {"StartPage": "209", "EndPage": "228", "MedlinePgn": "209-228"}, "Abstract": {"AbstractText": ["This chapter describes the potential use of flavopiridol, a CDK inhibitor with anti-inflammatory and anti-proliferative activities, in the treatment of various chronic diseases. Flavopiridol arrests cell cycle progression in the G1 or G2 phase by inhibiting the kinase activities of CDK1, CDK2, CDK4/6, and CDK7. Additionally, it binds tightly to CDK9, a component of the P-TEFb complex (CDK9/cyclin T), and interferes with RNA polymerase II activation and associated transcription. This in turn inhibits expression of several pro-survival and anti-apoptotic genes, and enhances cytotoxicity in transformed cells or differentiation in growth-arrested cells. Recent studies indicate that flavopiridol elicits anti-inflammatory activity via CDK9 and NF\u03baB-dependent signaling. Overall, these effects of flavopiridol potentiate its ability to overcome aberrant cell cycle activation and/or inflammatory stimuli, which are mediators of various chronic diseases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Morsani College of Medicine, University of South Florida, Tampa, Florida, 33612, USA."}], "LastName": "Srikumar", "ForeName": "Thejal", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, 33612, USA. jpadmana@health.usf.edu."}, {"Identifier": [], "Affiliation": "USF Health Byrd Alzheimer's Institute, University of South Florida, 4001 E. Fletcher Ave., Tampa, Florida, 33613, USA. jpadmana@health.usf.edu."}], "LastName": "Padmanabhan", "ForeName": "Jaya", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Adv Exp Med Biol", "NlmUniqueID": "0121103", "ISSNLinking": "0065-2598"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cardiovascular Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperidines"}, {"RegistryNumber": "45AD6X575G", "NameOfSubstance": "alvocidib"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Cardiovascular Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle Checkpoints"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Chronic Disease"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Discovery"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Piperidines"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "10", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "10", "Day": "25", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27771926", "10.1007/978-3-319-41342-6_9"]}}], "PubmedBookArticle": []}